Perrigo Operating Income 2011-2025 | PRGO
Perrigo operating income from 2011 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
|
Perrigo Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $113 |
| 2023 | $152 |
| 2022 | $79 |
| 2021 | $410 |
| 2020 | $265 |
| 2019 | $175 |
| 2018 | $237 |
| 2017 | $598 |
| 2016 | $-2,000 |
| 2015 | $68 |
| 2015 | $673 |
| 2014 | $571 |
| 2013 | $679 |
| 2012 | $569 |
| 2011 | $490 |
|
Perrigo Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-06-30 | $45 |
| 2025-03-31 | $47 |
| 2024-12-31 | $114 |
| 2024-09-30 | $80 |
| 2024-06-30 | $-27 |
| 2024-03-31 | $-55 |
| 2023-12-31 | $-16 |
| 2023-09-30 | $62 |
| 2023-06-30 | $57 |
| 2023-03-31 | $49 |
| 2022-12-31 | $31 |
| 2022-09-30 | $33 |
| 2022-06-30 | $-7 |
| 2022-03-31 | $22 |
| 2021-12-31 | $47 |
| 2021-09-30 | $438 |
| 2021-06-30 | $-126 |
| 2021-03-31 | $51 |
| 2020-12-31 | $38 |
| 2020-09-30 | $79 |
| 2020-06-30 | $63 |
| 2020-03-31 | $86 |
| 2019-12-31 | $-37 |
| 2019-09-30 | $54 |
| 2019-06-30 | $55 |
| 2019-03-31 | $102 |
| 2018-12-31 | $108 |
| 2018-09-30 | $-122 |
| 2018-06-30 | $95 |
| 2018-03-31 | $156 |
| 2017-12-31 | $159 |
| 2017-09-30 | $162 |
| 2017-06-30 | $149 |
| 2017-03-31 | $129 |
| 2016-12-31 | $-485 |
| 2016-09-30 | $-1,468 |
| 2016-06-30 | $185 |
| 2016-03-31 | $-232 |
| 2015-12-31 | $-490 |
| 2015-09-30 | $175 |
| 2015-06-30 | $192 |
| 2015-03-31 | $190 |
| 2014-12-31 | $1,072 |
| 2014-09-30 | $137 |
| 2014-06-30 | |
| 2014-03-31 | $103 |
| 2013-12-31 | $979 |
| 2013-09-30 | $180 |
| 2013-06-30 | |
| 2013-03-31 | $179 |
| 2012-12-31 | $883 |
| 2012-09-30 | $157 |
| 2012-06-30 | |
| 2012-03-31 | $146 |
| 2011-12-31 | $838 |
| 2011-09-30 | $102 |
| 2011-06-30 | |
| 2011-03-31 | $123 |
| 2010-12-31 | $718 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.949B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $224.002B | 25.82 |
| EssilorLuxottica (ESLOY) | France | $171.957B | 0.00 |
| Boston Scientific (BSX) | United States | $154.367B | 35.30 |
| Stryker (SYK) | United States | $140.480B | 27.89 |
| Medtronic (MDT) | Ireland | $122.894B | 17.33 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.851B | 0.00 |
| Agilent Technologies (A) | United States | $42.956B | 27.80 |
| ResMed (RMD) | United States | $36.903B | 25.54 |
| GE HealthCare Technologies (GEHC) | United States | $34.155B | 16.34 |
| Koninklijke Philips (PHG) | Netherlands | $28.291B | 18.48 |
| Insulet (PODD) | United States | $23.696B | 73.55 |
| Terumo (TRUMY) | Japan | $22.712B | 25.57 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.842B | 11.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.285B | 0.00 |
| Baxter (BAX) | United States | $9.613B | 7.76 |
| Sunny Optical Technology (SNPTF) | China | $9.339B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.828B | 31.74 |
| Demant (WILYY) | Denmark | $7.496B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $3.614B | 11.01 |
| ICU Medical (ICUI) | United States | $3.435B | 21.81 |
| Haemonetics (HAE) | United States | $3.423B | 15.23 |
| Envista Holdings (NVST) | United States | $3.308B | 18.98 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.120B | 0.00 |
| Prestige Consumer Healthcare (PBH) | United States | $2.910B | 13.27 |
| LeMaitre Vascular (LMAT) | United States | $2.041B | 41.08 |
| Curaleaf Holdings (CURLF) | Canada | $1.869B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.837B | 18.35 |
| AtriCure (ATRC) | United States | $1.644B | 0.00 |
| QuidelOrtho (QDEL) | United States | $1.535B | 9.86 |
| Green Thumb Industries (GTBIF) | United States | $1.452B | 63.64 |
| Neogen (NEOG) | United States | $1.406B | 26.96 |
| Tilray Brands (TLRY) | Canada | $1.381B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.378B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.261B | 18.27 |
| BioLife Solutions (BLFS) | United States | $1.248B | 370.29 |
| InMode (INMD) | Israel | $0.923B | 10.44 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.830B | 0.00 |
| Valneva SE (VALN) | France | $0.790B | 0.00 |
| Surmodics (SRDX) | United States | $0.591B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.513B | 17.64 |
| CeriBell (CBLL) | United States | $0.477B | 0.00 |
| Evolus (EOLS) | United States | $0.473B | 0.00 |
| SNDL (SNDL) | Canada | $0.470B | 0.00 |
| Omeros (OMER) | United States | $0.469B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.441B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.413B | 0.00 |
| Cerus (CERS) | United States | $0.317B | 0.00 |
| Brainsway (BWAY) | Israel | $0.300B | 52.60 |
| Sanuwave Health (SNWV) | United States | $0.286B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.286B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.285B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.268B | 0.00 |
| High Tide (HITI) | Canada | $0.258B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.255B | 151.00 |
| Viemed Healthcare (VMD) | United States | $0.249B | 19.85 |
| Quanterix (QTRX) | United States | $0.244B | 0.00 |
| Owens & Minor (OMI) | United States | $0.227B | 2.28 |
| TriSalus Life Sciences (TLSI) | United States | $0.220B | 0.00 |
| Exagen (XGN) | United States | $0.217B | 0.00 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.205B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.192B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.188B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.180B | 15.88 |
| FitLife Brands (FTLF) | United States | $0.178B | 21.93 |
| OraSure Technologies (OSUR) | United States | $0.177B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Biote (BTMD) | United States | $0.131B | 5.28 |
| Jushi Holdings (JUSHF) | United States | $0.114B | 0.00 |
| Sharps Technology (STSS) | United States | $0.104B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.102B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.101B | 0.00 |
| MacroGenics (MGNX) | United States | $0.093B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 13.38 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.055B | 32.26 |
| Nephros (NEPH) | United States | $0.048B | 35.08 |
| Jin Medical (ZJYL) | China | $0.042B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Veru (VERU) | United States | $0.040B | 0.00 |
| Zynex (ZYXI) | United States | $0.033B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Bonk (BNKK) | United States | $0.032B | 0.00 |
| United-Guardian (UG) | United States | $0.028B | 14.28 |
| Modular Medical (MODD) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.007B | 0.00 |
| Flora Growth (FLGC) | United States | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.005B | 0.00 |
| Akanda (AKAN) | Canada | $0.001B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |